Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease.
To elucidate the possible role of vitamin E in the pathogenesis of Parkinson's disease (PD), we compared serum levels of alpha-tocopherol (vitamin E), measured by high-performance liquid chromatography, and the vitamin E/cholesterol ratio of 42 Parkinson's disease (PD) patients using their spouses as the control group. The serum levels of vitamin E did not differ significantly between the groups (13.84 +/- 0.56 micrograms/ml for PD and 14.80 +/- 0.57 micrograms/ml for controls), nor did the vitamin E/cholesterol ratio (0.64 +/- 0.03 for both groups). There was no influence of antiparkinsonian therapy on vitamin E or the vitamin E/cholesterol ratio. Serum levels of the vitamin E and vitamin E/cholesterol ratio did not correlate with age, age at onset, scores of the Unified Parkinson's Disease Rating Scale or the Hoehn and Yahr staging in the PD group. These results suggest that serum vitamin E concentrations do not play a role in the pathogenesis of PD.
Férnandez-Calle
P
P
Department of Biochemistry, Hospital Severo Ochoa-Leganés, Madrid, Spain.
Molina
J A
JA
Jiménez-Jiménez
F J
FJ
Vázquez
A
A
Pondal
M
M
García-Ruiz
P J
PJ
Urra
D G
DG
Domingo
J
J
Codoceo
R
R
D000368:Aged; D000704:Analysis of Variance; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000097:blood*; D014810:Vitamin E / Q000097:blood*
D014810:Vitamin E